Commentary

Andrew Mammen

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1136
Number of pages1
JournalClinical Chemistry
Volume61
Issue number9
DOIs
StatePublished - Sep 1 2015
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl CoA Reductases
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Muscle Weakness
Muscular Diseases
Immunosuppressive Agents
Autoantibodies
Autoimmune Diseases
Muscles

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Commentary. / Mammen, Andrew.

In: Clinical Chemistry, Vol. 61, No. 9, 01.09.2015, p. 1136.

Research output: Contribution to journalArticle

Mammen, A 2015, 'Commentary', Clinical Chemistry, vol. 61, no. 9, pp. 1136. https://doi.org/10.1373/clinchem.2014.236869
Mammen, Andrew. / Commentary. In: Clinical Chemistry. 2015 ; Vol. 61, No. 9. pp. 1136.
@article{5c36d5b2213149319b46106ad9b09775,
title = "Commentary",
author = "Andrew Mammen",
year = "2015",
month = "9",
day = "1",
doi = "10.1373/clinchem.2014.236869",
language = "English (US)",
volume = "61",
pages = "1136",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "9",

}

TY - JOUR

T1 - Commentary

AU - Mammen, Andrew

PY - 2015/9/1

Y1 - 2015/9/1

UR - http://www.scopus.com/inward/record.url?scp=84952716865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952716865&partnerID=8YFLogxK

U2 - 10.1373/clinchem.2014.236869

DO - 10.1373/clinchem.2014.236869

M3 - Article

C2 - 26319450

AN - SCOPUS:84952716865

VL - 61

SP - 1136

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 9

ER -